Literature DB >> 20150261

Cellular dosimetry of (111)In using monte carlo N-particle computer code: comparison with analytic methods and correlation with in vitro cytotoxicity.

Zhongli Cai1, Jean-Philippe Pignol, Conrad Chan, Raymond M Reilly.   

Abstract

UNLABELLED: Our objective was to compare Monte Carlo N-particle (MCNP) self- and cross-doses from (111)In to the nucleus of breast cancer cells with doses calculated by reported analytic methods (Goddu et al. and Farragi et al.). A further objective was to determine whether the MCNP-predicted surviving fraction (SF) of breast cancer cells exposed in vitro to (111)In-labeled diethylenetriaminepentaacetic acid human epidermal growth factor ((111)In-DTPA-hEGF) could accurately predict the experimentally determined values.
METHODS: MCNP was used to simulate the transport of electrons emitted by (111)In from the cell surface, cytoplasm, or nucleus. The doses to the nucleus per decay (S values) were calculated for single cells, closely packed monolayer cells, or cell clusters. The cell and nucleus dimensions of 6 breast cancer cell lines were measured, and cell line-specific S values were calculated.
RESULTS: For self-doses, MCNP S values of nucleus to nucleus agreed very well with those of Goddu et al. (ratio of S values using analytic methods vs. MCNP = 0.962-0.995) and Faraggi et al. (ratio = 1.011-1.024). MCNP S values of cytoplasm and cell surface to nucleus compared fairly well with the reported values (ratio = 0.662-1.534 for Goddu et al.; 0.944-1.129 for Faraggi et al.). For cross doses, the S values to the nucleus were independent of (111)In subcellular distribution but increased with cluster size. S values for monolayer cells were significantly different from those of single cells and cell clusters. The MCNP-predicted SF for monolayer MDA-MB-468, MDA-MB-231, and MCF-7 cells agreed with the experimental data (relative error of 3.1%, -1.0%, and 1.7%). The single-cell and cell cluster models were less accurate in predicting the SF. For MDA-MB-468 cells, relative error was 8.1% using the single-cell model and -54% to -67% using the cell cluster model. Individual cell-line dimensions had large effects on S values and were needed to estimate doses and SF accurately.
CONCLUSION: MCNP simulation compared well with the reported analytic methods in the calculation of subcellular S values for single cells and cell clusters. Application of a monolayer model was most accurate in predicting the SF of breast cancer cells exposed in vitro to (111)In-DTPA-hEGF.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20150261     DOI: 10.2967/jnumed.109.063156

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  12 in total

1.  A model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy.

Authors:  Robert F Hobbs; Sébastien Baechler; De-Xue Fu; Caroline Esaias; Martin G Pomper; Richard F Ambinder; George Sgouros
Journal:  Med Phys       Date:  2011-06       Impact factor: 4.071

2.  Survival of tumor and normal cells upon targeting with electron-emitting radionuclides.

Authors:  Didier Rajon; Wesley E Bolch; Roger W Howell
Journal:  Med Phys       Date:  2013-01       Impact factor: 4.071

3.  Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.

Authors:  Dongyoul Lee; Mengshi Li; Bryan Bednarz; Michael K Schultz
Journal:  Radiat Res       Date:  2018-06-26       Impact factor: 2.841

4.  Monte Carlo simulation of irradiation and killing in three-dimensional cell populations with lognormal cellular uptake of radioactivity.

Authors:  Roger W Howell; Didier Rajon; Wesley E Bolch
Journal:  Int J Radiat Biol       Date:  2011-11-30       Impact factor: 2.694

5.  The Effect of Nucleus Size on the Cell Dose in Targeted Radionuclide Therapy - A Monte Carlo Study.

Authors:  Ebrahim Kouhkan; Nahid Chegeni; Amjad Hussain
Journal:  J Med Signals Sens       Date:  2020-04-25

6.  Trastuzumab labeled to high specific activity with ¹¹¹In by conjugation to G4 PAMAM dendrimers derivatized with multiple DTPA chelators exhibits increased cytotoxic potency on HER2-positive breast cancer cells.

Authors:  Conrad Chan; Zhongli Cai; Raymond M Reilly
Journal:  Pharm Res       Date:  2013-04-25       Impact factor: 4.200

7.  Interplay between the gold nanoparticle sub-cellular localization, size, and the photon energy for radiosensitization.

Authors:  Eli Lechtman; Jean-Philippe Pignol
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

8.  Synergism of peptide receptor-targeted Auger electron radiation therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors.

Authors:  Andreas Wicki; Damian Wild; Vincent Prêtre; Rosalba Mansi; Annette Orleth; Jean-Claude Reubi; Christoph Rochlitz; Christoph Mamot; Helmut R Mäcke; Gerhard Christofori
Journal:  EJNMMI Res       Date:  2014-02-16       Impact factor: 3.138

9.  Targeting Micrometastases: The Effect of Heterogeneous Radionuclide Distribution on Tumor Control Probability.

Authors:  Nadia Falzone; Boon Quan Lee; Sarah Able; Javian Malcolm; Samantha Terry; Yasir Alayed; Katherine Anne Vallis
Journal:  J Nucl Med       Date:  2018-06-29       Impact factor: 11.082

Review 10.  Auger electrons for cancer therapy - a review.

Authors:  Anthony Ku; Valerie J Facca; Zhongli Cai; Raymond M Reilly
Journal:  EJNMMI Radiopharm Chem       Date:  2019-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.